SEL-201

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameSEL-201

Drug Alias NameSEL-201

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase 2 inhibitorsMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors

TargetsMAP kinase-interacting serine/threonine-protein kinase MNK1MAP kinase-interacting serine/threonine-protein kinase 2

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMcGill University

China Registration ClassN/A

Develop Information

Active CompaniesMcGill University

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A